Valproic Acid in Combination With Bevacizumab and Oxaliplatin/Fluoropyrimidine Regimens in Patients With Ras-mutated Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Bevacizumab in Patients With Severe Covid-19
- Status
- UNKNOWN
- Phase
- PHASE3
A Phase II Study of Triple-negative Breast Cancer Brain Metastases.
- Status
- RECRUITING
- Phase
- PHASE2
Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols
- Status
- COMPLETED
- Phase
- PHASE1
Chemotherapy and Immunotherapy as Treatment for MSS Metastatic Colorectal Cancer With High Immune Infiltrate
- Status
- UNKNOWN
- Phase
- PHASE2
A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Tocotrienol and Bevacizumab in Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
ABC-lung: Atezolizumab, Bevacizumab and Chemotherapy in EGFR-mutant Non-small Cell Lung Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trial Assessing the Efficacy of Abscopal Effect Induced by SBRT and Immunotherapy in Advanced NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Brigatinib and Bevacizumab for the Treatment of ALK-Rearranged Locally Advanced, Metastatic, or Recurrent NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Radiomics Assess of Bevacizumab Plus Chemo in Colorectal Cancer Liver Metastases
- Status
- UNKNOWN
- Phase
- N/A
A Study of Bevacizumab, Carboplatin, and Paclitaxel or Pemetrexed With or Without Atezolizumab in Chemotherapy-Naïve Patients With Stage IV Non-Squamous Non-Small Cell Lung Cancer (IMpower151)
- Status
- COMPLETED
- Phase
- PHASE3
A Randomized Phase III Study Comparing Maintenance Treatment With Fluoropyrimidine + Bevacizumab Versus Fluoropyrimidine After Induction Chemotherapy for a Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Atezolizumab Plus Bevacizumab With HCC and HBV Infection
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Bevacizumab and Tocotrienol in Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trial in Chinese Healthy Volunteers of GB222
- Status
- UNKNOWN
- Phase
- PHASE1
Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America
- Status
- COMPLETED
- Phase
- N/A
Osimertinib With or Without Bevacizumab for EGFR- Mutant Non-small Cell Lung Cancer With Leptomeningeal Metastasis
- Status
- UNKNOWN
- Phase
- PHASE2